Media Center

We transform lives from fear and isolation to hope and freedom.

In the News

COVID-19 Update Fall 2021

Dr. Randhawa was asked to present to hundreds of medical staff physicians who are treating COVID focused on current events and the delta variant. We are pleased to share the presentation with you.

NBC LA Reaches Food Freedom!

NBC LA joined us as we reached food freedom for another patient! A huge congrats to the Ruiz family for this life-changing milestone. Watch and share the video to help us make this possible for more children with food allergies!

New food anaphylaxis study focuses specifically on almond allergy; Finds 71% of peanut-allergic patients have almond allergies

Studies of food anaphylaxis focused on almond allergy are rare. With food allergies increasing globally alongside an increase in almond consumption, a new study published in Food and Agricultural Immunology takes a focused look at almond allergies in pediatric food anaphylaxis patients. Titled "Demographic, clinical and diagnostic correlation of almond allergy in a cohort of nut allergy patients," Dr. Nathan Marsteller, Dr. Tricia Morphew and Dr. Inderpal Randhawa analyzed a cohort of 411 nut-allergic children to determine the prevalence of almond allergies. Their findings include a 67.7% occurrence of almond allergy, with approximately 25% of patients having both almond sensitivity and clinical reactivity. In relation to peanut allergies, 71.8% of patients with almond sensitivity and reactivity had peanut allergies and all patients with almond allergy had peanut allergy in this cohort. A better understanding of the relationships between food allergies is essential as more patients are receiving personalized care, such as through the Tolerance Induction Program at Southern California Food Allergy Institute.
Organization updates from our founder and CEO, Dr. Inderpal Randhawa
On March 21, 2021, TPIRC held a COVID safe employee event to hear from our Founder and CEO Dr. Inderpal Randhawa to talk about what the future holds for our organization.

We would like to share the future state of TPIRC/Southern California Food Allergy Institute with everyone who aligns with our mission.

TIP™ vs OIT Webinar

On Wednesday, June 30, the Founder and CEO of TPIRC and Southern California Food Allergy Institute, Dr. Inderpal Randhawa, held a live webinar to talk about the different treatment options for children with food anaphylaxis. In case you missed it, you can watch the video here.

Got Food Allergies? Discover a New Treatment that Can Reverse Life-Threatening Reactions

Philadelphia Magazine featured our CEO Dr. Inderpal Randhawa to share his expertise on food allergies. He discusses current food allergy treatment options like OIT, and how the Tolerance Induction Program (TIP™), is the only option for true food freedom.

Food Anaphylactic Children Not At Increased Risk For COVID-19 New Study Finds

Disease-specific COVID-19 pediatric cases have not been studied effectively to date. Much is unknown as to how COVID-19 impacts children with pre-existing conditions, such as anaphylactic food allergies. Researchers at the Translational Pulmonary and Immunology Research Center (TPIRC), MemorialCare Heath System, Miller Children's Hospital and Irvine School of Medicine compiled and analyzed serum samples of food anaphylactic, asymptomatic children from across the United States to determine their risk of COVID-19 seropositivity. The report, titled “Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort”, was published in the international, peer-reviewed open access journal Antibodies by MDPI. Their data suggests that this specific population - food anaphylaxis and highly atopic children - are not at increased risk for COVID-19 than the general population.

The study used blood samples collected between February 1 and April 20, 2020 from children and adolescents, between the ages of 4 and 18 years, prior to treatment at the Translational Pulmonary Immunology Research Center (TPIRC) in California. All patients were enrolled as part of a food anaphylaxis treatment program. At the time of collection, all patients were asymptomatic of any acute disease process and had not received any form of food immunotherapy. All blood samples were reviewed and approved by the Advarra Institutional Review Board.

A total of 172 blood samples were tested for COVID-19, with positive results in six patients (4%) who had no symptoms at the time of the blood draw. This seropositivity rate of 4% is equal or less than the risk for the general population at the time of testing in the early months of the pandemic. This concludes that patient sensitivity to five common allergens - peanut, sesame, cashew, hazelnut, and pecan - did not significantly relate to COVID-19 positivity.

“The results of our study are reassuring for parents who have children with food allergies,” says Dr. Nathan Marsteller, Director of Research at the Translational Pulmonary and Immunology Research Center. “The anxiety and stress of living with a food allergy is overwhelming,” he continues, “so I am happy to find that this specific population appears at either equal or potentially less risk than the general population.”

A notable finding was increased IgG4 in the COVID-19 positive group, nearly three times that of the negative group. IgG4 may play a role as a biomarker in the local inflammatory environment, a factor in lung disease associated with COVID-19. The elevated serum IgG4 specific to viral infection risk is novel in this study and requires further research as a potential risk factor for COVID-19 infection.

A full copy of the study can be found here:

Southern California Food Allergy Institute Expands To New Clinic

Largest food allergy and anaphylaxis treatment center of its kind helps more children achieve Food Freedom

LONG BEACH, CA (May 07, 2021) - The Southern California Food Allergy Institute (SCFAI) today opened the doors to their new Willow Clinic located in Signal Hill, CA. The largest site expansion in SCFAI history, since its founding in 2015, comes after a year of continued patient care throughout the pandemic, marking significant growth in demand for the revolutionizing food allergy and anaphylaxis treatment program.

Known for their Tolerance Induction Program (TIP™), the specialized treatment program is entirely dependent on a patient's data and uniquely tailored to their food allergy needs. Built on over a decade of diagnostic data collected, with a 99% success rate TIP™ has helped over 10,000 children with food allergies and anaphylaxis achieve true Food Freedom - the ability to eat whatever they want, whenever they want, in unlimited quantities, without fear of reaction.

“The opening of this second clinic is a milestone for our organization, “said Founder and Chief Executive Officer Dr. Inderpal Randhawa. “We are here with these children every step of the way,” he added, “expanding our resources and team so we can help more children with food allergies achieve a life-changing Food Freedom.”

The new Willow Clinic will be located at 2704 E. Willow Street in Signal Hill, CA, conveniently close to Headquarters and downtown Long Beach. All food challenge visits will take place at the new clinic, providing patients and their families a familiar environment to pass their challenges and safely eat an adult-sized dose of an allergic food.

About Us:
Our non-profit, the Southern California Food Allergy Institute is a division in the Translational Pulmonary and Immunology Research Center (TPIRC). It is a cutting-edge clinical care and research center that is revolutionizing food allergy treatment. We are dedicated to providing innovative and safe treatment for the six million children in the United States who suffer from food allergies and anaphylaxis. Our goal is simple — for all children to safely eat whatever they want, in any amount - without the fear of a reaction.

Live Billing Q&A

On Wednesday, May 5, the Founder and CEO of TPIRC and Southern California Food Allergy Institute, Dr. Inderpal Randhawa, and Christopher Clay, Billing Operations Manager, held a live Q&A with over 147 families to answer questions about billing. In case you missed it, you can watch the video here.

Live COVID Q&A Event
On December 17, 2020, Dr. Inderpal Randhawa, TPIRC and SoCal Food Allergy Founder and CEO, held a live Q&A with over 503 families to answer audience questions about the latest details on COVID-19, vaccines, and more.
Dr. Randhawa Receives the COVID Vaccine
“Last week I received the Pfizer COVID-19 vaccine, without any issues. As I continue to treat patients with COVID-19 in area hospitals, I remain confident this surge will stabilize in the next few weeks, with the combination of the vaccine and the total case numbers pushing the curve down during the next month. While LA County and Southern California are currently experiencing a significant surge of COVID-19 cases, SoCal Food Allergy continues to be a COVID-safe zone for our patients and their families, as well as our staff.

The next possible surge may be at the end of March, and with proper vaccine administration and response, there is hope that won't happen. Please stay focused. You control your risk. Together, we can make our environments safe by following the guidelines to protect ourselves and our loved ones.” — Dr. Inderpal Randhawa, Founder, CEO, and Chief Medical Officer of SCFAI
SoCal Food Allergy Food Freedom Event
On December 1, 2020, over 279 families around the globe joined Dr. Inderpal Randhawa, and food allergy parents, Lisa Kammel and John Gallegos, to learn about SoCal Food Allergy's Tolerance Induction Program. Learn what true Food Freedom is all about.
Dr. Randhawa on KTLA, Sept. 5, 2020

Leading Food Anaphylaxis Physician and Scientist Inderpal Randhawa, M.D., Urges Parents to 'Not Let Your Guard Down' This Holiday Season

Dec. 7, 2020

AI Helping Children Achieve Freedom from Food Allergies

Nov. 30, 2020

Leading Medical Researcher and Food Allergy Pioneer Inderpal Randhawa, M.D., Named 2020 Recipient of the Prestigious Munzer Family Lifetime Achievement Award

Nov. 27, 2020

Food Allergies: “It's life and death.”

Oct. 1, 2020

Life-Saving Treatment in a COVID-Safe Zone

Aug. 25, 2020

Removing Risk Of Food Allergies In Children

Aug. 25, 2020

Media Contact

Judith Rontal